The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
MM+M Podcast 8.16.22: What’s really keeping pharma from prioritizing the patient?
Hensley Evans of ZS Associates drops in to discuss her new book on patient-centricity, and why pharma is taking so long to put patients at the forefront.
MM+M Podcast 8.9.22: The creators who visualized ‘the wild beast’ of mental illness
MM+M’s Stephen Madden sits down with Janis Cohen and Dan Weber of Havas Health & You to discuss their pro-bono work seeking to destigmatize mental illness and more.
MM+M Podcast 8.2.22: Could biopharma M&A ramp up in the second half?
Subin Baral, global life sciences deals leader at EY, shares his research-based predictions for where biopharma dealmaking could be headed in the second half.
MM+M Podcast 7.26.22: SCAN Health’s $1M bid to reduce racial disparities
Sharon Jhawar, chief pharmacy officer, and Timshel Tarbet, VP of business excellence and diversity strategy, discuss the plan’s effort to reduce disparities in medication adherence.
MM+M Podcast 7.19.22: J&J’s Tylenol embraces ‘beyond the pill’
Adam Ricciardone, global head of self care R&D at Johnson & Johnson Consumer Health, discusses how Tylenol embraced a “beyond-the-pill” strategy.
DTC Dialogues: Iris Yim, VP, Asian American Advertising Federation and founder/president, Sparkle Insights, Inc.
MM+M’s Stephen Madden speaks with Iris Yim, VP, Asian American Advertising Federation and Founder/ President, Sparkle Insights, Inc. about confronting anti-Asian bias and more.
DTC Dialogues: Horace Clark, VP of account management, BlackDoctor.org
MM+M’s Stephen Madden speaks with Horace Clark, vp of account management, BlackDoctor.org, about understanding and working to overcome the Black community’s distrust of the healthcare system.
DTC Dialogues: iHeartMedia’s John Liliquist
MM+M’s Stephen Madden speaks with John Liliquist, SVP Health, iHeartMedia, about the state of the union for terrestrial radio, how health brands are evolving their targeting and measurement approaches for broadcast audio, and more.
MM+M Podcast 7.12.22: Why the FDA needs a new PR whisperer
Wayne Pines joins the show to discuss a recent report that the agency is looking to tap a skilled public communicator to improve its messaging.
MM+M Podcast 7.5.22: Pharma’s reputation is settling into a ‘new normal’
Rob Jekielek, managing director of the Harris Poll, comments on reputational data showing that pharma’s positive image is still high above pre-pandemic levels.
MM+M Podcast 6.28.22: Highlights from MM+M’s Women of Distinction 2022 educational summit
From the panel discussions to the keynote fireside, here are audio snippets and commentary from MM+M’s Women of Distinction 2022 educational summit.
Live at Cannes – Wunderman Thompson Health’s Patrick Wisnom
Patrick Wisnom, the new CEO of Wunderman Thompson Health, explains what it’s like to be back in Cannes after the festival’s three-year hiatus, opines on the drop in awards entries, and more.
Live at Cannes – Klick Health’s Rich Levy and Bernardo Romero
Klick Health’s Rich Levy, chief creative officer, and Bernardo Romero, maker, share their impressions of the winning work and more.
Live at Cannes – Cleveland Clinic’s Paul Matsen
In this mini-episode, Steve Madden talks with Paul Matsen, chief marketing and communications officer for the Cleveland Clinic.
Live at Cannes — Area 23’s Franklin Williams
Franklin Williams, a Pharma Lions juror who’s also EVP, director of experience design at Area 23, talks about his experience as a jurist and Area 23’s two Lion-winning campaigns.
MM+M Podcast 6.14.22: Why Europe wants to close the orphan drug loophole
Preferential treatment for orphan drugs is very much in play overseas. Jack Mycka, VP in the PRMA division of Indegene, explains what potential European reforms could mean for pharma marketers.
MM+M Podcast 6.6.22: The 2022 Agency 100 preview
Larry Dobrow and Marc Iskowitz discuss what to expect — and how to get the most out of — MM+M’s Agency 100 content package, which goes live Tuesday, June 7.
MM+M Podcast 5.24.22: Road to board diversity hits a speed bump
Lisa Suennen, a healthcare VC, opines on whether the voiding of California’s Women on Boards law by an L.A. judge may hamper ongoing board diversity efforts.
MM+M Podcast 5.17.22: Will abortion marketing spike if Roe v. Wade is rolled back?
With SCOTUS poised to strike down Roe v. Wade, telemedicine abortion providers are ramping up their communication about safe access.
MM+M Podcast 5.11.22: Highlights from MM+M Transform 2022
From the opening keynote to the closing one, here are audio snippets from the full MM+M Transform program.
